02196 FOSUN PHARMA
- 13.240
- 0.0000.00%
FOSUN PHARMA News
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration of a Subsidiary
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration of a Subsidiary
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Progress of Drug Clinical Trial By a Subsidiary
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement Regarding Subsidiary's Approval for Pharmaceutical Clinical Trials
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Acceptance of a Subsidiary's Drug Registration Application
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Acceptance ofa Subsidiary's Drug Registration Application
FOSUN PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: Overseas Regulatory Announcement - Advisory announcement regarding the progress of absorption merger and privatization of the holding subsidiary HENLIUS Biotechnology Co., Ltd.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement regarding the pledge of part of the Shareholder's shares.
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement Regarding the Signing of a Licensing Agreement by a Wholly-Owned Subsidiary.
FOSUN PHARMA: CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
FOSUN PHARMA: Overseas regulatory announcement - Progress announcement on the absorption merger and privatization of the holding subsidiary henlius biotechnology co., ltd.
No Data
